Label-free, real-time monitoring of IgE-mediated mast cell activation on microelectronic cell sensor arrays.

Immunoglobulin E (IgE)-mediated mast cell activation is involved in the immediate phase of allergic reactions and plays a central role in the onslaught and persistence of allergic diseases. IgE-mediated mast cell activation includes two important events: cell sensitization resulting from IgE binding to Fc (FcepsilonRI) receptor and cell activation triggered by allergen-mediated oligomerization of membrane-bound IgE. Real-time monitoring of these events is needed to dissect the molecular mechanisms underlying IgE-mediated mast cell activation. Existing technologies are limited to label-based end-point assay formats, which detect either early signaling or final phase of mast cell activation. We describe a microelectronic cell sensor-based technology allowing dynamic monitoring of IgE-mediated mast cell sensitization and activation in real-time without any labeling steps. RBL-2H3 mast cells were cultured onto the surface of microelectronic cell sensor arrays integrated into the bottom of microtiter plates, which record electric properties, such as impedance between cell membrane and sensor surface. In the presence of the allergen, dinitrophenyl (DNP)-bovine serum albumin (BSA), anti-DNP IgE-sensitized cells were activated within 5 min and the entire activation process was quantitatively and continuously recorded. Impedance measurements correlate with morphological dynamics and mediator release as measured by beta-hexosaminidase activity, and can be blocked by pharmacological agents, inhibiting IgE-mediated signaling. The assay on microelectronic cell sensor arrays can be scaled up for high-throughput screening of pharmacological inhibitors of IgE-mediated mast cell activation and other cell-based receptor-ligand assays.

[1]  M. Triggiani,et al.  Pharmacological modulation of human mast cells and basophils , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[2]  D. Corry,et al.  Induction and regulation of the IgE response , 1999, Nature.

[3]  J. Rivera.  Molecular adapters in Fc(epsilon)RI signaling and the allergic response. , 2002, Current opinion in immunology.

[4]  David Fear,et al.  The biology of IGE and the basis of allergic disease. , 2001, Annual review of immunology.

[5]  J. Rivera.  Molecular adapters in FcεRI signaling and the allergic response , 2002 .

[6]  A. Tedeschi,et al.  Effects of protein kinase C and phospholipase C inhibitors on IgE-dependent and IgE-independent basophil histamine release , 2000, Inflammation Research.

[7]  J. Apgar,et al.  The role of actin microfilaments in the down-regulation of the degranulation response in RBL-2H3 mast cells. , 1999, Journal of immunology.

[8]  J. Warner,et al.  A sensitive colorimetric assay for the release of tryptase from human lung mast cells in vitro. , 1993, Journal of immunological methods.

[9]  P. French,et al.  Focal adhesion formation is associated with secretion of allergic mediators. , 1995, Cell motility and the cytoskeleton.

[10]  I. Giaever,et al.  Prostaglandin E2 elicits a morphological change in cultured orbital fibroblasts from patients with Graves ophthalmopathy. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Kinet,et al.  Signalling through the high-affinity IgE receptor FcεRI , 1999, Nature.

[12]  C. Lo,et al.  Cell-substrate contact: another factor may influence transepithelial electrical resistance of cell layers cultured on permeable filters. , 1999, Experimental cell research.

[13]  David T. Jones,et al.  Continual production of phosphatidic acid by phospholipase D is essential for antigen-stimulated membrane ruffling in cultured mast cells. , 2002, Molecular biology of the cell.

[14]  Q. Hamid,et al.  Inflammatory cells in asthma: mechanisms and implications for therapy. , 2003, The Journal of allergy and clinical immunology.

[15]  J. Oliver,et al.  Regulation and Roles of the Membrane, Cytoskeletal and Adhesive Responses of RBL-2H3 Rat Tumor Mast Cells to FcεRI Crosslinking , 1997 .

[16]  B. Wilson,et al.  Inhibition of mast cell Fc epsilon R1-mediated signaling and effector function by the Syk-selective inhibitor, piceatannol. , 1994, The Journal of biological chemistry.

[17]  S. Holgate,et al.  New targets for allergic rhinitis — a disease of civilization , 2003, Nature Reviews Drug Discovery.

[18]  Toshiaki Kawakami,et al.  Regulation of mast-cell and basophil function and survival by IgE , 2002, Nature Reviews Immunology.

[19]  E. Auerswald,et al.  A new, highly sensitive enzymic assay for human tryptase and its use for identification of tryptase inhibitors. , 1990, Biological chemistry Hoppe-Seyler.

[20]  J. Dastych,et al.  Relations between Fc epsilon RI crosslinking-induced mast cell activation and adhesion to fibronectin. , 1994, Journal of Physiology and Pharmacology.

[21]  G. G. Deanin,et al.  Membrane and cytoskeletal changes associated with IgE-mediated serotonin release from rat basophilic leukemia cells , 1985, The Journal of cell biology.

[22]  S. Demo,et al.  Quantitative measurement of mast cell degranulation using a novel flow cytometric annexin-V binding assay. , 1999, Cytometry.

[23]  P. French,et al.  PMA and calcium ionophore induce myosin and F-actin rearrangement during histamine secretion from RBL-2H3 cells. , 1994, Cell motility and the cytoskeleton.

[24]  A. Denman.  Cellular and Molecular Immunology , 1992 .

[25]  Ivar Giaever,et al.  A morphological biosensor for mammalian cells , 1993, Nature.

[26]  K. Austen,et al.  The Diverse Roles of Mast Cells , 2001, The Journal of experimental medicine.

[27]  S. Nakashima,et al.  Brefeldin A inhibits antigen- or calcium ionophore-mediated but not PMA-induced phospholipase D activation in rat basophilic leukemia (RBL-2H3) cells. , 1996, Immunobiology.

[28]  M. Wakelam,et al.  Antigen-stimulated activation of phospholipase D1b by Rac1, ARF6, and PKCalpha in RBL-2H3 cells. , 2002, Molecular biology of the cell.

[29]  J. Kinet,et al.  Signalling through the high-affinity IgE receptor Fc epsilonRI. , 1999, Nature.

[30]  Ivar Giaever,et al.  Use of Electric Fields to Monitor the Dynamical Aspect of Cell Behavior in Tissue Culture , 1986, IEEE Transactions on Biomedical Engineering.

[31]  J. Rivera,et al.  ER-27319, an acridone-related compound, inhibits release of antigen-induced allergic mediators from mast cells by selective inhibition of fcepsilon receptor I-mediated activation of Syk. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[32]  I. Giaever,et al.  Micromotion of mammalian cells measured electrically. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[33]  T. Aramaki,et al.  Establishment of an assay method for human mast cell chymase. , 2002, Hepatology research : the official journal of the Japan Society of Hepatology.

[34]  P. Dráber,et al.  Src family‐selective tyrosine kinase inhibitor, PP1, inhibits both FcεRI‐ and Thy‐1‐mediated activation of rat basophilic leukemia cells , 1997, European journal of immunology.

[35]  B. Baird,et al.  Evidence supporting a role for microfilaments in regulating the coupling between poorly dissociable IgE-Fc epsilonRI aggregates downstream signaling pathways. , 1997, Biochemistry.

[36]  I. Giaever,et al.  Monitoring fibroblast behavior in tissue culture with an applied electric field. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[37]  I. Giaever,et al.  Prostaglandin E2 alters human orbital fibroblast shape through a mechanism involving the generation of cyclic adenosine monophosphate. , 1995, The Journal of clinical endocrinology and metabolism.

[38]  E. Corey,et al.  IgE-mediated release of leukotriene C4, chondroitin sulfate E proteoglycan, beta-hexosaminidase, and histamine from cultured bone marrow-derived mouse mast cells , 1983, The Journal of experimental medicine.